Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion (MPE) in non-squamous non-small cell lung cancer (NSCLC) patients with MPE unsuccessfully controlled by tube drainage or pleurodesis (North East Japan Study Group Trial NEJ-013B-2).

Rintaro Noro,Kunihiko Kobayashi,Jiro Usuki,Yukio Hosomi,Masaru Nishitsuji,Hiroaki Okamoto,Mitsunori Hino,Koichi Hagiwara,Akihiko Miyanaga,Masahiro Seike,Kaoru Kubota,Akihiko Gemma

Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion (MPE) in non-squamous non-small cell lung cancer (NSCLC) patients with MPE unsuccessfully controlled by tube drainage or pleurodesis (North East Japan Study Group Trial NEJ-013B-2).

2017

Rintaro Noro
Kunihiko Kobayashi
Jiro Usuki
Yukio Hosomi
Masaru Nishitsuji
Hiroaki Okamoto
Mitsunori Hino
Koichi Hagiwara
Akihiko Miyanaga
Masahiro Seike
Kaoru Kubota
Akihiko Gemma

e21660Background: Prospective and retrospective studies on intrapleural therapy of malignant pleural effusion (MPE) have reported that the success rate for controlling pleural effusion was 50–70% a...

Keywords:

Tube drainage
Bevacizumab
Gastroenterology
Phases of clinical research
Squamous non-small cell lung cancer
Malignant pleural effusion
Pathology
Pleurodesis
Internal medicine
Medicine
Chemotherapy
Pleural effusion
non-small cell lung cancer (NSCLC)
Retrospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations